ClinConnect ClinConnect Logo
Search / Trial NCT06901180

In Our Study We Compare Results of Two Oncoplastic Breast Surgery (short Scar Reduction Mammoplasty and Wise Pattern Reduction Mammoplasty) As Surgical Treatment of Breast Cancer

Launched by SOHAG UNIVERSITY · Mar 22, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical techniques used in oncoplastic breast surgery for women with breast cancer. The study compares a method called short scar reduction mammoplasty with another method known as wise pattern reduction mammoplasty. Both techniques aim to treat breast cancer while also considering the cosmetic outcome, meaning how the breast will look after surgery.

To participate in this study, women between the ages of 25 and 75 who have operable breast cancer (stages I, II, or IIIa) and have moderate to large breasts may be eligible. However, those with certain conditions or previous treatments that could complicate surgery, like multiple tumors or previous radiation therapy, won't be included. If you join the trial, you will receive one of the two surgical techniques being studied, and the results will help researchers understand which method might be better for patients in terms of both cancer treatment and appearance after surgery.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Female patients with ages ranging from 25 to 75 years.
  • 2. Patients with operable breast cancer (Stage I, II and IIIa).
  • 3. Patients with moderate to large /ptotic breasts.
  • Exclusion Criteria:
  • 1. Patients with a contraindication to breast conservative surgery:
  • 1. Multi-centric disease that can't be incorporated by local excision through a single incision that achieves adequate safety margin and satisfactory cosmetic results.
  • 2. inflammatory carcinoma.
  • 3. Contraindications to postoperative radiation e.g. pregnancy, pre-existing lung disease with reduced diffusing capacity and pulmonary TB.
  • 4. diffuse suspicious malignant micro-calcification on mammography.
  • 5. inability to attain negative surgical margins.
  • 6. cardiomyopathy
  • 7. connective tissue disorders with significant vasculitis.
  • 2. Previous chest wall or breast radiation.
  • 3. Patients' refusal participation.

About Sohag University

Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.

Locations

Sohag, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported